124 related articles for article (PubMed ID: 37192608)
1. MiRNA-520a-3p combined with folic acid conjugated Fe
Li X; Wang S; Gao Q; Li N; Dong S; Gao Y; Wang Z; Zhang B; He X
Nanotechnology; 2023 Jun; 34(37):. PubMed ID: 37192608
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine inhibits cell malignancy in osteosarcoma cells via miR-520a-3p-YOD1 interactome.
Yan R; Jin S; Liu H; Le C; Gao J; Cheng J; Chen L; Li N
Biochem Biophys Res Commun; 2021 Mar; 543():56-64. PubMed ID: 33515913
[TBL] [Abstract][Full Text] [Related]
3. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
4. Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis.
Wu PF; Tang XM; Sun HL; Jiang HT; Ma J; Kong YH
Neoplasma; 2021 Jul; 68(4):798-809. PubMed ID: 34348465
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable FePS
Luo T; Jiang M; Cheng Z; Lin Y; Chen Y; Zhang Z; Zhou J; Zhou W; Yu XF; Li S; Geng S; Yang H
J Nanobiotechnology; 2023 Jul; 21(1):224. PubMed ID: 37443019
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine-modified ZIF-8 nanoparticles as a drug carrier for combined chemo-photothermal osteosarcoma therapy.
Yin X; Ran S; Cheng H; Zhang M; Sun W; Wan Y; Shao C; Zhu Z
Colloids Surf B Biointerfaces; 2022 Aug; 216():112507. PubMed ID: 35523102
[TBL] [Abstract][Full Text] [Related]
7. Polydopamine-Coated Manganese Carbonate Nanoparticles for Amplified Magnetic Resonance Imaging-Guided Photothermal Therapy.
Cheng Y; Zhang S; Kang N; Huang J; Lv X; Wen K; Ye S; Chen Z; Zhou X; Ren L
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19296-19306. PubMed ID: 28508635
[TBL] [Abstract][Full Text] [Related]
8. Actively targeted gold-polydopamine (PDA@Au) nanocomplex for sequential drug release and combined synergistic chemo-photothermal therapeutic effects.
Singh S; Pal K
Int J Pharm; 2023 Oct; 645():123374. PubMed ID: 37673278
[TBL] [Abstract][Full Text] [Related]
9. CeO
Zhang J; Hu M; Wen C; Liu J; Yu F; Long J; Lin XC
Biomed Mater; 2023 Sep; 18(6):. PubMed ID: 37683677
[TBL] [Abstract][Full Text] [Related]
10. cRGD-Conjugated Fe
Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress in Xenograft Mouse Model Exposed to Dendrimers Decorated Polydopamine Nanoparticles and Targeted Chemo- and Photothermal Therapy.
Witkowska M; Mrówczyński R; Grześkowiak B; Miechowicz I; Florek E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068888
[TBL] [Abstract][Full Text] [Related]
12. Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe
Mirrahimi M; Hosseini V; Kamrava SK; Attaran N; Beik J; Kooranifar S; Ghaznavi H; Shakeri-Zadeh A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):241-253. PubMed ID: 29291635
[TBL] [Abstract][Full Text] [Related]
13. LINC01614 promotes osteosarcoma progression via miR-520a-3p/SNX3 axis.
Cai Q; Zhao X; Wang Y; Li S; Wang J; Xin Z; Li F
Cell Signal; 2021 Jul; 83():109985. PubMed ID: 33753211
[TBL] [Abstract][Full Text] [Related]
14. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of multifunctional ferric oxide nanoparticles for tumor-targeted magnetic resonance imaging and precise photothermal therapy with magnetic field enhancement.
Liu J; Chen H; Fu Y; Li X; Chen Y; Zhang H; Wang Z
J Mater Chem B; 2017 Nov; 5(43):8554-8562. PubMed ID: 32264523
[TBL] [Abstract][Full Text] [Related]
17. MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.
Li J; Shao W; Zhao J
Hum Cell; 2021 Mar; 34(2):570-578. PubMed ID: 33196969
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine green-loaded polydopamine-iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy.
Hu D; Liu C; Song L; Cui H; Gao G; Liu P; Sheng Z; Cai L
Nanoscale; 2016 Oct; 8(39):17150-17158. PubMed ID: 27539790
[TBL] [Abstract][Full Text] [Related]
19. A multifunctional α-Fe
Odda AH; Cheang TY; Alesary HF; Liu L; Qian X; Ullah N; Wang G; Pan Y; Xu AW
J Mater Chem B; 2022 Mar; 10(9):1453-1462. PubMed ID: 35188170
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance/Infrared Dual-Modal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy Nanoplatform Based on Cu
Cheng L; Sang D; Zhao F; Yang L; Guo Z; Zhang X; Yang Q; Qiao W; Sun X; Guan X; Wang H; Wang J; Zou H; Li X; Fang F; Li Y; Zhang S; Wu L; Lin H; Sun X; Wang K
J Colloid Interface Sci; 2022 Jun; 615():95-109. PubMed ID: 35124510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
